Literature DB >> 12467394

Solid-phase synthesis of amine-bridged cyclic enkephalin analogues via on-resin cyclization utilizing the Fukuyama-Mitsunobu reaction.

Yosup Rew1, Murray Goodman.   

Abstract

An efficient solid-phase synthetic route is described for the preparation of 13-membered amine-bridged cyclic enkephalin analogues (ABEs) 1a and 1c-1j (Figure 1) resulting from a sulfonamide-containing peptide whose backbone is bound to a resin. The Fukuyama-Mitsunobu reaction of the 2-nitrobenzenesulfonyl-protected amine bound to the solid support with protected aminoethanol in the presence of triphenylphosphine and diisopropyl azodicarboxylate (DIAD) is utilized to prepare a resin-bound sulfonamide-protected secondary amine. After peptide cyclization, this protected amine functionality becomes the "amine bridge" of the target molecule. In addition, the reagent DIAD was found to be a superior reagent compared to diethyl azodicarboxylate (DEAD) in the solid-phase Fukuyama-Mitsunobu reaction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467394     DOI: 10.1021/jo020447l

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  Design, synthesis, and biological evaluation of new cyclic melanotropin peptide analogues selective for the human melanocortin-4 receptor.

Authors:  Jinfa Ying; Xuyuan Gu; Minying Cai; Matthew Dedek; Josef Vagner; Dev B Trivedi; Victor J Hruby
Journal:  J Med Chem       Date:  2006-11-16       Impact factor: 7.446

2.  A fluorous-tagged linker from which small molecules are released by ring-closing metathesis.

Authors:  Stuart G Leach; Christopher J Cordier; Daniel Morton; Gordon J McKiernan; Stuart Warriner; Adam Nelson
Journal:  J Org Chem       Date:  2008-03-08       Impact factor: 4.354

Review 3.  Fukuyama reduction, Fukuyama coupling and Fukuyama-Mitsunobu alkylation: recent developments and synthetic applications.

Authors:  Sana Sikandar; Ameer Fawad Zahoor; Shazia Naheed; Bushra Parveen; Kulsoom Ghulam Ali; Rabia Akhtar
Journal:  Mol Divers       Date:  2021-02-11       Impact factor: 2.943

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.